Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Yan-Ruide Li, Ying Fang, Shaoqiang Niu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Boosting CAR-T cell therapy through vaccine synergy
Yan-Ruide Li, Zibai Lyu, Xinyuan Shen, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 2
Frontiers in CAR-T cell therapy for autoimmune diseases
Yan-Ruide Li, Zibai Lyu, Yuning Chen, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 839-857
Open Access | Times Cited: 13
Frontiers in artificial intelligence‐directed light‐sheet microscopy for uncovering biological phenomena and multiorgan imaging
Enbo Zhu, Yan‐Ruide Li, Samuel Margolis, et al.
View (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 6
Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 5
iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
Jiepu Zong, Yan-Ruide Li
Bioengineering (2025) Vol. 12, Iss. 1, pp. 60-60
Open Access
Synthetic Biology‐Based Engineering Cells for Drug Delivery
Wenzhe Yi, Songnian Hu, Xindi Qian, et al.
Exploration (2025)
Open Access
Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture
Yan-Ruide Li, Kuangyi Zhou, Derek Lee, et al.
Nature Protocols (2025)
Closed Access
Pluripotent stem cell-based immunotherapy: advances in translational research, cell differentiation, and gene modifications
Qi Lei, Hongkui Deng, Shicheng Sun
Life Medicine (2025) Vol. 4, Iss. 1
Open Access
Allogeneic chimeric antigen receptors (CARs) as an “off-the-shelf” therapy in multiple myeloma
Sophie G. Carlson, Tasha Lin, Sarah Larson
Immunotherapy (2025), pp. 1-12
Open Access
The clinical landscape of CAR-engineered unconventional T cells
Yan-Ruide Li, Yichen Zhu, Yuning Chen, et al.
Trends in cancer (2025)
Open Access
Protocol to profile tumor and microenvironment from ovarian cancer patient samples and evaluate cell-based therapy using in vitro killing assays
Yan-Ruide Li, Christopher Ochoa, Zibai Lyu, et al.
STAR Protocols (2025) Vol. 6, Iss. 2, pp. 103742-103742
Closed Access
The role of immunotherapy in targeting tumor microenvironment in genitourinary cancers
Ecem Kalemoglu, Yash Jani, Kübra Canaslan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hematopoietic stem cell conditioned media induces apoptosis in colorectal cancer stem cells via dysregulation of HSP90 and 26S proteasome system
Sumit Mallick, Vanya Kadla Narayana, Akhila Balakrishna, et al.
The International Journal of Biochemistry & Cell Biology (2025), pp. 106773-106773
Closed Access
Emerging Role of Chimeric Antigen Receptor-Natural Killer Cells for the Treatment of Hematologic Malignancies
Ugo Testa, Germana Castelli, Elvira Pelosi
Cancers (2025) Vol. 17, Iss. 9, pp. 1454-1454
Open Access
Breaking the mold: Unconventional T cells in cancer therapy
Yan-Ruide Li, Kuangyi Zhou, Yichen Zhu, et al.
Cancer Cell (2024)
Closed Access | Times Cited: 2
The surveillance of viral infections by the unconventional Type I NKT cell
Varshini Rajashekar, Lauren Stern, Catarina F. Almeida, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Interleukin 15‐Presenting Nanovesicles with Doxorubicin‐Loaded Ferritin Cores for Cancer Immunochemotherapy
Yi­hui Zhai, Wen Zhang, Jinming Wang, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
Pin Mei Yao, Yaguang Liu, Gang Huang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
A milestone method to make natural killer T cells
Leonid S. Metelitsa
Nature Biotechnology (2024)
Closed Access
Bona fidecytotoxic iNKT cells with superior antitumour responses identified in mice and humans
Carolina de Amat Herbozo, Stephanie WY Wong, Meggie Kuypers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Revolutionizing Immunotherapy: Unveiling New Horizons, Confronting Challenges, and Navigating Therapeutic Frontiers in CAR-T Cell-Based Gene Therapies
Shivani Srivastava, Anuradha Tyagi, Vishakha Anand Pawar, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 413-433
Open Access
Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia
Huynh Cao, Jeffrey Xiao, David J. Baylink, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2250-2250
Open Access
Page 1

Scroll to top